
### [NCIT:C95871](http://purl.obolibrary.org/obo/NCIT_C95871)
**Label:** Gastric Neuroendocrine Tumor

**Subclasses:** [NCIT:C135049](http://purl.obolibrary.org/obo/NCIT_C135049) (Stage IV Gastric Neuroendocrine Tumor AJCC v8), [NCIT:C135048](http://purl.obolibrary.org/obo/NCIT_C135048) (Stage III Gastric Neuroendocrine Tumor AJCC v8), [NCIT:C135047](http://purl.obolibrary.org/obo/NCIT_C135047) (Stage II Gastric Neuroendocrine Tumor AJCC v8), [NCIT:C135046](http://purl.obolibrary.org/obo/NCIT_C135046) (Stage I Gastric Neuroendocrine Tumor AJCC v8), [NCIT:C95880](http://purl.obolibrary.org/obo/NCIT_C95880) (Gastric Neuroendocrine Tumor G2), [NCIT:C135045](http://purl.obolibrary.org/obo/NCIT_C135045) (Gastric Neuroendocrine Tumor by AJCC v8 Stage), 

**Class expressions from DL-Learner:**

- [NCIT:C36133](http://purl.obolibrary.org/obo/NCIT_C36133) (Well Differentiated Lesion) 66.67%
- [NCIT:C36132](http://purl.obolibrary.org/obo/NCIT_C36132) (Poorly Differentiated Lesion) 66.67%
- [NCIT:C18254](http://purl.obolibrary.org/obo/NCIT_C18254) (MEN1 Gene) 66.67%
- [NCIT:C42078](http://purl.obolibrary.org/obo/NCIT_C42078) (Lesion by Morphology) 52.94%
- Thing 51.13%
- [NCIT:C3824](http://purl.obolibrary.org/obo/NCIT_C3824) (Lesion) 42.17%
- [NCIT:C35867](http://purl.obolibrary.org/obo/NCIT_C35867) (Morphologic Finding) 36.96%
- [NCIT:C83490](http://purl.obolibrary.org/obo/NCIT_C83490) (Microscopic Finding) 36.82%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 35.85%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 35.25%
- [NCIT:C20420](http://purl.obolibrary.org/obo/NCIT_C20420) (Transcription Factor Gene) 24.29%
- [NCIT:C54362](http://purl.obolibrary.org/obo/NCIT_C54362) (Transcription Regulation Gene) 22.69%
- [NCIT:C16612](http://purl.obolibrary.org/obo/NCIT_C16612) (Gene) 19.66%
- CP:0000037 0.00%
- CP:0000035 0.00%


